BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1801884)

  • 21. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
    Bruckner HW; Storch JA; Brown JC; Goldberg J; Chamberlin K
    Oncology; 1983; 40(3):165-9. PubMed ID: 6405338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
    Wadler S; Damle S; Haynes H; Kaleya R; Schechner R; Berkenblit R; Ladner RD; Murgo A
    J Clin Oncol; 1999 Jun; 17(6):1771-8. PubMed ID: 10561214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
    Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of chemotherapy for advanced adenocarcinoma of the pancreas in combined modality therapy.
    Kato H; Wakasugi H; Yokota M; Furukawa M; Mukuta T; Yamada Y; Funakoshi A
    Intern Med; 1994 Mar; 33(3):142-6. PubMed ID: 8061389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas.
    Scher RM; Kosierowski R; Lusch C; Alexander R; Fox S; Redei I; Green F; Raskay B; Amfoh K; Engstrom PF; O'Dwyer PJ
    Invest New Drugs; 1996; 13(4):347-54. PubMed ID: 8824355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
    Burch PA; Ghosh C; Schroeder G; Allmer C; Woodhouse CL; Goldberg RM; Addo F; Bernath AM; Tschetter LK; Windschitl HE; Cobau CD
    Am J Clin Oncol; 2000 Oct; 23(5):534-7. PubMed ID: 11039519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
    Erlichman C; Donehower RC; Speyer JL; Klecker R; Chabner BA
    J Natl Cancer Inst; 1982 Feb; 68(2):227-31. PubMed ID: 6950156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
    Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
    J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.
    Saif MW; Lansigan F; Ruta S; Lamb L; Mezes M; Elligers K; Grant N; Jiang ZL; Liu SH; Cheng YC
    Phytomedicine; 2010 Mar; 17(3-4):161-9. PubMed ID: 20092990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of oral rubitecan in previously treated pancreatic cancer patients.
    Burris HA; Rivkin S; Reynolds R; Harris J; Wax A; Gerstein H; Mettinger KL; Staddon A
    Oncologist; 2005 Mar; 10(3):183-90. PubMed ID: 15793221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 1-hexylcarbamoyl-5-fluorouracil on spontaneous mammary adenocarcinoma of mice.
    Tokuzen R; Iigo M; Hoshi A; Kuretani K
    Gan; 1980 Oct; 71(5):724-8. PubMed ID: 7227721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.
    Micke O; Hesselmann S; Bruns F; Horst E; Devries A; Schüller P; Willich N; Schäfer U
    Anticancer Res; 2005; 25(3A):1523-30. PubMed ID: 16033054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer.
    Sugimachi K; Maehara Y
    Surg Today; 2000; 30(12):1067-72. PubMed ID: 11193737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of HCFU and radiation therapy in head and neck cancer].
    Taketa C
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2169-74. PubMed ID: 3717961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.